Crown BioScience

Activities: Research & Development

Trending Articles

  1. Thermo Fisher Scientific officially opens US oral solid dose testing and R&D facility The company's further expansion in the Bend, Oregon area will assist its pharmaceutical clients in the early development of oral solid dosage (OSD) forms
  2. Stablepharma and AJ Vaccines to sign a distribution deal for SPVX02 AJ Vaccines will be responsible for the distribution and commercialisation of the fridge-free adult booster vaccine for tetanus and diphtheria across Europe
  3. Reckitt expands US OTC manufacturing footprint with North Carolina facility The site in Wilson will be responsible for producing Mucinex® branded tablets and liquids, which are designed as over the counter (OTC) medicines for cold and flu symptoms
  4. Modular automated flow synthesis of spirocyclic THNs from primary alkylamines Asynt and the Cresswell Group achieve advances in drug discovery scaffolds
  5. Amgen invests $1bn into new US drug manufacturing facility The site will be the CDMO's second drug substance manufacturing facility in North Carolina, and will boost its presence in the US pharmaceutical market

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

Related Content

Finance

JSR Life Sciences companies form Japanese joint venture

Based in Tokyo, the venture will establish a local team led by an experienced General Manager, Hiroki Itou
Research & Development

Crown Bioscience opens oncology biomarker R&D centre in California

New custom-designed 32,000 sqft facility in San Diego to support the growth of both oncology biomarker and inflammation service portfolios
Research & Development

Crown Bioscience and Charles River agree to expand access to ZDSD rat model

The agreement enables greater global model availability for drug discovery in obesity, diabetes and metabolic syndrome
Research & Development

Crown Bioscience creates Center of Excellence for bioinformatics, big data and biomarker discovery

Services and capacity increase with new site opening
Research & Development

Crown Bioscience expands cardiovascular and metabolic disease research capability

The company offers new non-GLP services and translational rodent models at its expanded site in Louisiana
Research & Development

CrownBio expands humanised models for targeted immunotherapy

The humanised model expansion programme will begin with PD-1, CTLA-4 and CD137 models
Research & Development

Grant awarded to doctors researching innovative PDX models in immuno-oncology

Crown Bioscience awarded Dr Lavial and his colleagues the grant due to their project's potential to create breakthroughs in preclinical oncology strategies
Subscribe now